Page last updated: 2024-09-04

ws 79089b and Cardiac Failure

ws 79089b has been researched along with Cardiac Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, M; Kinoshita, M; Matsumoto, T; Ohnishi, M; Tsutamoto, T; Wada, A; Wang, X; Yamamoto, T1
Emoto, N1
Fukai, D; Kinoshita, M; Maeda, Y; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A1
Ergul, A; Grubbs, AL; Spinale, FG; Zhang, Y1
Fujii, M; Kinoshita, M; Kurokawa, K; Matsumoto, T; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A; Wang, X; Yamada, H; Yamamoto, T1

Reviews

1 review(s) available for ws 79089b and Cardiac Failure

ArticleYear
[Physiological and pathophysiological roles of the endothelin converting enzymes].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles

2004

Other Studies

4 other study(ies) available for ws 79089b and Cardiac Failure

ArticleYear
Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Aldosterone; Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glomerular Filtration Rate; Heart Failure; Metalloendopeptidases; Models, Animal; Pulmonary Wedge Pressure; Renal Circulation; Tetracyclines

2002
Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Circulation, 1999, Feb-02, Volume: 99, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Blood Pressure; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Heart; Heart Failure; Hemodynamics; Indoles; Kidney; Male; Neuropeptides; Pulmonary Wedge Pressure; Receptor, Endothelin A; Tetracyclines; Time Factors; Vascular Resistance

1999
Selective upregulation of endothelin converting enzyme-1a in the human failing heart.
    Journal of cardiac failure, 2000, Volume: 6, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Aspartic Acid Endopeptidases; Cardiomyopathy, Dilated; Case-Control Studies; Endothelin-Converting Enzymes; Gene Expression Regulation; Heart Failure; Heart Transplantation; Heart Ventricles; Humans; Metalloendopeptidases; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Tetracyclines; Thiophenes; Up-Regulation

2000
Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
    Life sciences, 2001, Oct-12, Volume: 69, Issue:21

    Topics: Animals; Aspartic Acid Endopeptidases; Dogs; Endothelin-1; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Immunohistochemistry; Male; Metalloendopeptidases; Tetracyclines

2001